Seguin, J.; El Hajjam, M.; Legagneux, J.; Diakhaby, S.; Mignet, N.; Boudy, V.; Toussaint, B.; Peschaud, F.; Emile, J.F.; Capron, C.;
et al. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics 2024, 16, 315.
https://doi.org/10.3390/pharmaceutics16030315
AMA Style
Seguin J, El Hajjam M, Legagneux J, Diakhaby S, Mignet N, Boudy V, Toussaint B, Peschaud F, Emile JF, Capron C,
et al. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics. 2024; 16(3):315.
https://doi.org/10.3390/pharmaceutics16030315
Chicago/Turabian Style
Seguin, Johanne, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, Vincent Boudy, Balthazar Toussaint, Frederique Peschaud, Jean François Emile, Claude Capron,
and et al. 2024. "Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma" Pharmaceutics 16, no. 3: 315.
https://doi.org/10.3390/pharmaceutics16030315
APA Style
Seguin, J., El Hajjam, M., Legagneux, J., Diakhaby, S., Mignet, N., Boudy, V., Toussaint, B., Peschaud, F., Emile, J. F., Capron, C., & Malafosse, R.
(2024). Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics, 16(3), 315.
https://doi.org/10.3390/pharmaceutics16030315